Xylem price target raised to $170 from $165 at Argus

Argus raised the firm’s price target on Xylem (XYL) to $170 from $165 and keeps a Buy rating on the shares. The firm expects Xylem to benefit from trends in water conservation and drinking-water sanitation, as well as from evolving government regulatory programs in the U.S., Europe, and the U.K., the analyst tells investors in a research note. The firm also expects the acquisition of water treatment solutions company Evoqua to help accelerate growth by providing complementary services and solutions for Xylem customers, Argus added.